Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

54.35
Delayed Data
As of Feb 17
 +0.05 / +0.09%
Today’s Change
36.24
Today|||52-Week Range
62.50
+0.74%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close54.30
Today’s open54.35
Day’s range53.90 - 55.05
Volume279,948
Average volume (3 months)327,566
Market cap$1.8B
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+4.76%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+13.23%
P/E ratio20.5
Price/Sales3.63
Price/Book4.34

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+1.38+4.26%
PTLAPortola Pharmaceutic...+1.41+4.66%
LXRXLexicon Pharmaceutic...+0.19+1.22%
PCRXPacira Pharmaceutica...+0.30+0.69%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts


Search for Jobs